Translational Development Acquisition Corp. (TDACU) Income from Continuing Operations (2024 - 2026)

Translational Development Acquisition (TDACU) has 3 years of Income from Continuing Operations data on file, last reported at 281161.0 in Q1 2026.

• Quarterly Income from Continuing Operations rose 19.07% year-over-year to 281161.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 878291.0 (changed N/A YoY) and the FY2025 annual result came in at 944538.0, down 381.03% from the prior year.
• Income from Continuing Operations declined to 281161.0 in Q1 2026, from 162345.0 in the prior quarter.
• In the past five years, Income from Continuing Operations ranged from a high of 61283.0 in Q3 2024 to a low of 347408.0 in Q1 2025.
• A 3-year average of 202910.29 and a median of 213658.0 in 2025 frame the typical range for Income from Continuing Operations.
• Annual changes were most pronounced in 2025 — Income from Continuing Operations slumped 248.64% — and 2026, when it grew 19.07%.
• Tracing TDACU's Income from Continuing Operations over 3 years: stood at 133390.0 in 2024, then retreated by 21.71% to 162345.0 in 2025, then sank by 73.19% to 281161.0 in 2026.
• The last three Income from Continuing Operations figures came in at 281161.0 (Q1 2026), 162345.0 (Q4 2025), and 213658.0 (Q3 2025), per Business Quant data.